OXOID PBP2 1 LATEX AGGLUTINATION TEST

System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies

OXOID, LTD.

The following data is part of a premarket notification filed by Oxoid, Ltd. with the FDA for Oxoid Pbp2 1 Latex Agglutination Test.

Pre-market Notification Details

Device IDK011710
510k NumberK011710
Device Name:OXOID PBP2 1 LATEX AGGLUTINATION TEST
ClassificationSystem, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies
Applicant OXOID, LTD. WADE RD. Basingstoke, Hampshire,  GB Rg24 8pw
ContactA. Hollingsworth
CorrespondentA. Hollingsworth
OXOID, LTD. WADE RD. Basingstoke, Hampshire,  GB Rg24 8pw
Product CodeMYI  
CFR Regulation Number866.1640 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-06-04
Decision Date2002-04-02

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05032384096442 K011710 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.